company background image
LNTH logo

Lantheus Holdings NasdaqGM:LNTH Stock Report

Last Price

US$78.22

Market Cap

US$5.4b

7D

-1.8%

1Y

-14.1%

Updated

26 May, 2024

Data

Company Financials +

Lantheus Holdings, Inc.

NasdaqGM:LNTH Stock Report

Market Cap: US$5.4b

LNTH Stock Overview

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Lantheus Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lantheus Holdings
Historical stock prices
Current Share PriceUS$78.22
52 Week HighUS$94.47
52 Week LowUS$50.20
Beta0.52
1 Month Change19.31%
3 Month Change14.79%
1 Year Change-14.09%
3 Year Change222.56%
5 Year Change226.05%
Change since IPO1,116.49%

Recent News & Updates

Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus

May 23

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

May 10
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Lantheus Holdings: Powerful First Quarter

May 05

Recent updates

Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus

May 23

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

May 10
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Lantheus Holdings: Powerful First Quarter

May 05

Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Apr 12
Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Lantheus Holdings: Undervalued With A Good Outlook

Feb 28

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Feb 24
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Feb 08
Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Jan 03
Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing

Dec 16
Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing

A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Nov 28
A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?

Nov 09
Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?

Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down

Sep 04
Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down

Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Aug 09
Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Jul 22
Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

May 29
Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Apr 16
Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal

Feb 27
Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal

An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued

Jan 16
An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued

Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Dec 24
Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Oct 31
Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Oct 04
Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Looking In On Lantheus Holdings

Sep 14

Lantheus Holdings a buy at B Riley on growth spurred by approval of imaging agent

Aug 25

Lantheus Non-GAAP EPS of $0.89 beats by $0.19, revenue of $223.72M beats by $19.21M

Aug 04

Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

Jul 22
Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

Lantheus Holdings Rules The Medical Diagnostics Business World

Jul 06

We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Jun 25
We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Shareholder Returns

LNTHUS Medical EquipmentUS Market
7D-1.8%-1.2%-0.2%
1Y-14.1%5.5%25.6%

Return vs Industry: LNTH underperformed the US Medical Equipment industry which returned 5.5% over the past year.

Return vs Market: LNTH underperformed the US Market which returned 25.4% over the past year.

Price Volatility

Is LNTH's price volatile compared to industry and market?
LNTH volatility
LNTH Average Weekly Movement6.2%
Medical Equipment Industry Average Movement8.1%
Market Average Movement5.9%
10% most volatile stocks in US Market16.0%
10% least volatile stocks in US Market2.8%

Stable Share Price: LNTH's share price has been volatile over the past 3 months.

Volatility Over Time: LNTH's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1956834Brian Markisonwww.lantheus.com

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer.

Lantheus Holdings, Inc. Fundamentals Summary

How do Lantheus Holdings's earnings and revenue compare to its market cap?
LNTH fundamental statistics
Market capUS$5.42b
Earnings (TTM)US$460.53m
Revenue (TTM)US$1.37b

11.8x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LNTH income statement (TTM)
RevenueUS$1.37b
Cost of RevenueUS$491.31m
Gross ProfitUS$874.31m
Other ExpensesUS$413.78m
EarningsUS$460.53m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.64
Gross Margin64.02%
Net Profit Margin33.72%
Debt/Equity Ratio59.4%

How did LNTH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.